Skip to main content
. 2018 Aug 14;2018(8):CD012327. doi: 10.1002/14651858.CD012327.pub2
Summary for the risk of pregnancy‐induced hypertension in women with GDM
No conclusions possible: low‐ to very low‐quality evidence, or insufficient evidence to comment on the effectiveness, more evidence needed
  • Moderate‐quality evidence showed no clear difference for metformin versus glibenclamide.

  • Low‐quality evidence showed no clear difference for glibenclamide versus placebo or insulin regimen A versus B.

  • Very low‐quality evidence showed no clear difference for low‐ versus high‐carbohydrate diet; high‐ versus low‐unsaturated fat diet with matching calories; and ethnic specific diet versus standard healthy diet